Coagulation Factor Concentrates Market
Coagulation Factor Concentrates Market Analysis By Type (Coagulation Factor IX, Coagulation Factor XIII & Other Types) By End-User (Hospitals & Clinics, Research Laboratories & Academic Institutions) By Region – Global Market Insights 2022 to 2027
Analysis of Coagulation Factor Concentrates market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Coagulation Factor Concentrates Market Outlook (2022-2027)
In 2022, the global coagulation factor concentrates market is valued at US$ 7.8 billion and is predicted to climb to US$ 11.4 billion by the end of 2027. Worldwide demand for coagulation factor concentrates is anticipated to rise at a high-value CAGR of 7.8% over the next five years.
Coagulation factor XIII is anticipated to witness high demand owing to the rising incidence of hemophilia and its better-quality safety profile than other factor concentrates.
Report Attributes |
Details |
|---|---|
|
Coagulation Factor Concentrates Market Size (2022) |
US$ 7.8 Billion |
|
Projected Market Value (2027F) |
US$ 11.4 Billion |
|
Global Market Growth Rate (2022-2027) |
7.8% CAGR |
|
China Market Value (2027F) |
US$ 2.5 Billion |
|
United States Market Value (2022) |
US$ 2 Billion |
|
Germany Market Growth Rate (2022-2027) |
4.5% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Sales Analysis of Coagulation Factor Concentrates (2017-2021) in Comparison to Market Forecasts (2022-2027)
The world has witnessed a prominent increase in the incidence of blood disorders over the past decade and this has led to a rise in demand for blood disorder treatments. Blood clotting factor concentrates play a crucial role in the treatment of different blood-related disorders and since the incidence of these disorders is on the rise, it is projected to boost demand for coagulation factor concentrates through 2027.
The market for coagulation factor concentrates is set to evolve at a high CAGR of 7.8% over the next five years. Increasing prevalence of Von Willebrand disease and disseminated intravascular coagulation (DIC) disorder is also projected to favor coagulation factor concentrates market growth over the years to come.
Rising adoption of prophylaxis treatment, growing incidence of hemophilia in newborns, upsurge in demand for hemophilia treatment, and high investments in healthcare research and development are other factors that could potentially uplift coagulation factor concentrates market growth over the next five years.
However, the high costs of blood disorder treatments and lack of awareness of blood disorders in developing economies are anticipated to have a hindering effect on the overall coagulation factor concentrates market potential.
Stringent regulatory mandates implemented by governments across the world to ensure patient safety are expected to slow down coagulation factor concentrates market growth across the forecast period.
A detailed assessment of the current as well as forecasted trends, restraints, and opportunities has been listed in this latest coagulation factor concentrates market research report by Fact.MR, a market research and competitive intelligence provider.
Which Factors are Anticipated to Shape the Coagulation Factor Concentrates Market?
“High Incidence of Hemophilia to Favor Clotting Factor Concentrate Demand”
The world has witnessed a notable increase in the prevalence of hemophilia and other blood disorders over the past few years and this trend is projected to follow a similar stance over the coming years and contribute to hemophilia treatment market size expansion.
Surging awareness of hemophilia and government initiatives to ensure affordable treatment are expected to propel the demand for coagulation factor concentrate therapies, plasma-derived coagulation factor concentrates, recombinant clotting factors, etc.
The coagulation factor concentrates market is also expected to benefit from the rising incidence of hemophilia and increasing disease awareness across the world. Coagulation factor XIII is a preferred choice in severe hemophilia treatment and is expected to witness a rise in demand owing to its better quality safety profile.
“High Cost of Blood Disorder Treatment to Hurt Coagulation Factor Concentrate Sales”
Blood disorder treatments are expensive in nature and this factor is expected to restrain the adoption of these treatment procedures, which is expected to negatively impact coagulation factor concentrate demand over the coming years. Moreover, the limited spending potential of patients in underdeveloped and developing economies and strict regulatory norms are also expected to have a hindering effect on the overall coagulation factor concentrates market potential through 2027.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Will the Coagulation Factor Concentrates Industry Fare Across Geographies?
“North America & Europe to Spearhead Global Coagulation Factor Concentrates Market Growth”
The North America coagulation factor concentrates market is projected to account for a prominent market share in the global industry landscape throughout the forecast period.
Rapid adoption of novel treatments, the presence of developed healthcare infrastructure, and increasing investments in the healthcare research and development sector are expected to prominently augment coagulation factor concentrate demand in this region through 2027. The market for coagulation factor concentrates in Canada is predicted to evolve at a CAGR of 6.4% over the next five years.
Investments to improve healthcare infrastructure and increasing supportive government initiatives to boost awareness of blood disorders are expected to favor coagulation factor concentrate sales in Europe over the coming years. Key countries that coagulation factor concentrate suppliers should keep an eye out for in this region are France, Italy, Germany, and the United Kingdom.
The Germany coagulation factor concentrates market is anticipated to exhibit expansion at a CAGR of around 4.5% through 2027.
The Asia Pacific coagulation factor concentrates market is anticipated to be driven by an increasing blood-related disorder-affected patient pool and rising investments in healthcare infrastructure development. India is anticipated to be one of the key markets for coagulation factor concentrates owing to the high prevalence of hemophilia in the country.
The coagulation factor concentrates market in China is also expected to be highly opportune owing to the rising focus on healthcare infrastructure development and rising awareness of blood disorders. Demand for coagulation factor concentrates in China is anticipated to rise at a CAGR of 12% over the next five years and hold a value of US$ 2.5 billion by the end of 2027.
Country-wise Insights
What is the Demand Outlook for Coagulation Factor Concentrates in the United States?
“High Research Activity & Rising Availability of Blood Disorder Treatments to Drive U.S. Coagulation Factor Concentrate Sales”
The market for coagulation factor concentrates in the United States is anticipated to be driven by rising investments in the R&D sector and the growing prevalence of blood disorders. High healthcare expenditure and growing adoption of new treatments and therapies are expected to favor the bleeding disorders treatment market and subsequently drive coagulation factor concentrate demand as well.
An increase in government spending to promote research and development activity and initiatives to increase awareness of blood-related disorders are also expected to positively influence coagulation factor concentrates market potential in the U.S.
In 2022, sales of coagulation factor concentrates in the United States account for a revenue value of US$ 2 billion.
Category-wise Insights
Which Type of Coagulation Factor Concentrate Will Exhibit High Demand?
“Coagulation Factor XIII to Lead Market Expansion Going Forward”
The global coagulation factor concentrates market, based on type, is segmented into coagulation factor IX, coagulation factor XIII, and other types.
Demand for coagulation factor XIII is anticipated to be higher than coagulation factor IX owing to its better safety profile and extensive use in the treatment of hemophilia A and hemophilia B diseases. Development of coagulation factor XIII involves virus inactivation similar to plasma-derived coagulation factor concentrates and hence results in a better quality safety profile.
This research on the coagulation factor concentrates industry also provides detailed insights on how demand for coagulation factor IX and other types of coagulation factors is expected to fare over the years to come.
Which End User Will Account for High Uptake of Coagulation Factor Concentrates?
“Research Laboratories to Witness High Demand for Clotting Factor Concentrates”
The coagulation factor concentrates market, based on end user, is bifurcated into hospitals & clinics, research laboratories, and academic institutions.
Investments in research and development in the healthcare industry have increased exponentially over the past few years owing to the rising prevalence of chronic blood disorders. The aforementioned factor is anticipated to drive demand for coagulation factor concentrates in research laboratories and the increasing establishment of research labs across the world is expected to further bolster demand through 2027.
Increasing awareness of blood disorder treatments and supportive initiatives to promote the same are expected to propel sales of coagulation factor concentrates in hospitals and clinics over the years to come.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape :
Coagulation factor concentrate providers are focusing on expanding their revenue generation capacity by getting new approval for their products from regulatory authorities.
- In July 2022, Novo Nordisk, a Danish multinational pharmaceutical organization, announced that the United States Food and Drug Administration (FDA) had approved REBINYN®, Coagulation Factor IX, GlycoPEGylated for regular prophylaxis in adults and children. REBINYN is a recombinant DNA-derived coagulation factor IX concentrate.
Other recent developments by key companies such as Baxter International Inc., Octapharma, LFB, Biotest, Green Cross Corporation, Shanghai RAAS Blood Products, and Sanquin have also been listed in this new market study on the coagulation factor concentrates industry.
Key Segments in Coagulation Factor Concentrates Industry Research
-
By Type :
- Coagulation Factor IX
- Coagulation Factor XIII
- Other Types
-
By End User :
- Hospitals & Clinics
- Research Laboratories
- Academic Institutions
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type launches 5.2.2. Cost of Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Type 6.4.2. Revenue By End User 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Coagulation Factor Concentrates Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2021 7.2. Current and Future Market Volume (Units) Projections, 2022-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Coagulation Factor Concentrates Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Coagulation Factor Concentrates Market Value Analysis 2017–2021 and Forecast, 2022-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Types & Services, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2027 10.3.1. Coagulation Factor IX 10.3.2. Coagulation Factor XIII 10.3.3. Other Types 10.4. Market Attractiveness Analysis By Type 11. Global Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2027 11.3.1. Hospitals & Clinics 11.3.2. Research Laboratories 11.3.3. Academic Institutions 11.4. Market Attractiveness Analysis By End User 12. Global Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Coagulation Factor Concentrates Market Analysis 2017–2021 and Forecast 2022-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Coagulation Factor Concentrates Market Analysis 20.2.1. By Type 20.2.2. By End User 20.3. Canada Coagulation Factor Concentrates Market Analysis 20.3.1. By Type 20.3.2. By End User 20.4. Mexico Coagulation Factor Concentrates Market Analysis 20.4.1. By Type 20.4.2. By End User 20.5. Brazil Coagulation Factor Concentrates Market Analysis 20.5.1. By Type 20.5.2. By End User 20.6. U.K. Coagulation Factor Concentrates Market Analysis 20.6.1. By Type 20.6.2. By End User 20.7. Germany Coagulation Factor Concentrates Market Analysis 20.7.1. By Type 20.7.2. By End User 20.8. France Coagulation Factor Concentrates Market Analysis 20.8.1. By Type 20.8.2. By End User 20.9. Italy Coagulation Factor Concentrates Market Analysis 20.9.1. By Type 20.9.2. By End User 20.10. Spain Coagulation Factor Concentrates Market Analysis 20.10.1. By Type 20.10.2. By End User 20.11. BENELUX Coagulation Factor Concentrates Market Analysis 20.11.1. By Type 20.11.2. By End User 20.12. Russia Coagulation Factor Concentrates Market Analysis 20.12.1. By Type 20.12.2. By End User 20.13. China Coagulation Factor Concentrates Market Analysis 20.13.1. By Type 20.13.2. By End User 20.14. Japan Coagulation Factor Concentrates Market Analysis 20.14.1. By Type 20.14.2. By End User 20.15. South Korea Coagulation Factor Concentrates Market Analysis 20.15.1. By Type 20.15.2. By End User 20.16. India Coagulation Factor Concentrates Market Analysis 20.16.1. By Type 20.16.2. By End User 20.17. ASEAN Coagulation Factor Concentrates Market Analysis 20.17.1. By Type 20.17.2. By End User 20.18. Australia Coagulation Factor Concentrates Market Analysis 20.18.1. By Type 20.18.2. By End User 20.19. New Zealand Coagulation Factor Concentrates Market Analysis 20.19.1. By Type 20.19.2. By End User 20.20. GCC Countries Coagulation Factor Concentrates Market Analysis 20.20.1. By Type 20.20.2. By End User 20.21. Turkey Coagulation Factor Concentrates Market Analysis 20.21.1. By Type 20.21.2. By End User 20.22. South Africa Coagulation Factor Concentrates Market Analysis 20.22.1. By Type 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. CSL Behring 22.3.1.1. Overview 22.3.1.2. Type Portfolio 22.3.1.3. Profitability by Market Segments (Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Shire 22.3.2.1. Overview 22.3.2.2. Type Portfolio 22.3.2.3. Profitability by Market Segments (Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Kedrion S.P.A. 22.3.3.1. Overview 22.3.3.2. Type Portfolio 22.3.3.3. Profitability by Market Segments (Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Grifols 22.3.4.1. Overview 22.3.4.2. Type Portfolio 22.3.4.3. Profitability by Market Segments (Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Baxter International Inc. 22.3.5.1. Overview 22.3.5.2. Type Portfolio 22.3.5.3. Profitability by Market Segments (Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Octapharma 22.3.6.1. Overview 22.3.6.2. Type Portfolio 22.3.6.3. Profitability by Market Segments (Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. LFB 22.3.7.1. Overview 22.3.7.2. Type Portfolio 22.3.7.3. Profitability by Market Segments (Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Novo Nordisk A/S 22.3.8.1. Overview 22.3.8.2. Type Portfolio 22.3.8.3. Profitability by Market Segments (Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Biotest 22.3.9.1. Overview 22.3.9.2. Type Portfolio 22.3.9.3. Profitability by Market Segments (Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Green Cross Corporation 22.3.10.1. Overview 22.3.10.2. Type Portfolio 22.3.10.3. Profitability by Market Segments (Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Shanghai RAAS Blood Products 22.3.11.1. Overview 22.3.11.2. Type Portfolio 22.3.11.3. Profitability by Market Segments (Type/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Sanquin 22.3.12.1. Overview 22.3.12.2. Type Portfolio 22.3.12.3. Profitability by Market Segments (Type/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Bio Product Laboratory 22.3.13.1. Overview 22.3.13.2. Type Portfolio 22.3.13.3. Profitability by Market Segments (Type/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. Medscape 22.3.14.1. Overview 22.3.14.2. Type Portfolio 22.3.14.3. Profitability by Market Segments (Type/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Coagulation Factor Concentrates Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Type
Table 02: Global Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 03: Global Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 04: Global Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 06: North America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 07: North America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 08: Latin America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 09: Latin America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 10: Latin America Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 11: Europe Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 12: Europe Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 13: Europe Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 14: South Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 15: South Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 16: South Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 17: East Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 18: East Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 19: East Asia Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 20: Oceania Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 21: Oceania Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 22: Oceania Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 23: Middle East and Africa Coagulation Factor Concentrates Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 24: Middle East and Africa Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 25: Middle East and Africa Coagulation Factor Concentrates Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Coagulation Factor Concentrates Market Volume (in 000' Units) Analysis, 2017-2021
Figure 02: Global Coagulation Factor Concentrates Market Volume Forecast (in 000' Units), 2022-2027
Figure 03: Coagulation Factor Concentrates Pricing Analysis (US$) Per Type, By Region, 2021
Figure 04: Coagulation Factor Concentrates Pricing Analysis (US$) Per Type, By Region, 2021
Figure 05: Global Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 06: Global Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 07: Global Coagulation Factor Concentrates Market Absolute $ Opportunity, 2022-2027
Figure 08: Global Coagulation Factor Concentrates Market Share Analysis (%), By Type, 2022-2027
Figure 09: Global Coagulation Factor Concentrates Market Y-o-Y Analysis (%), By Type, 2022-2027
Figure 10: Global Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 11: Global Coagulation Factor Concentrates Market Share Analysis (%), By End User, 2022-2027
Figure 12: Global Coagulation Factor Concentrates Market Y-o-Y Analysis (%), By End User, 2022-2027
Figure 13: Global Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 14: Global Coagulation Factor Concentrates Market Share Analysis (%), By Region, 2022-2027
Figure 15: Global Coagulation Factor Concentrates Market Y-o-Y Analysis (%), By Region, 2022-2027
Figure 16: Global Coagulation Factor Concentrates Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 18: North America Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 19: North America Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 20: North America Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 21: North America Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 22: North America Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 23: North America Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 24: North America Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 25: Latin America Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 26: Latin America Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 29: Latin America Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 30: Latin America Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 31: Latin America Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 32: Latin America Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 33: Europe Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 34: Europe Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 35: Europe Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 36: Europe Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 37: Europe Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 38: Europe Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 39: Europe Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 40: Europe Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 41: South Asia Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 42: South Asia Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 45: South Asia Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 46: South Asia Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 47: South Asia Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 48: South Asia Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 49: East Asia Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 50: East Asia Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 53: East Asia Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 54: East Asia Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 55: East Asia Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 56: East Asia Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 57: Oceania Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 58: Oceania Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 61: Oceania Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 62: Oceania Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 63: Oceania Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 64: Oceania Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 65: Middle East and Africa Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 66: Middle East and Africa Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Coagulation Factor Concentrates Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2017-2021
Figure 69: Middle East and Africa Coagulation Factor Concentrates Market Value Forecast (US$ Mn), 2022-2027
Figure 70: Middle East and Africa Coagulation Factor Concentrates Market Attractiveness Analysis by Type, 2022-2027
Figure 71: Middle East and Africa Coagulation Factor Concentrates Market Attractiveness Analysis by End User, 2022-2027
Figure 72: Middle East and Africa Coagulation Factor Concentrates Market Attractiveness Analysis by Country, 2022-2027
Figure 73: U. S. Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 75: U. S. Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 76: Canada Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 78: Canada Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 81: Mexico Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 84: Brazil Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 87: U. K. Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 88: Germany Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 90: Germany Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 91: France Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 93: France Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 94: Italy Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 96: Italy Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 97: Spain Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 99: Spain Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 100: Russia Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 102: Russia Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 103: China Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 105: China Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 106: Japan Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 108: Japan Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 111: South Korea Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 112: India Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 114: India Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 117: ASEAN Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 118: Australia Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 120: Australia Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 123: New Zealand Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 126: GCC Countries Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 129: Turkey Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Coagulation Factor Concentrates Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Coagulation Factor Concentrates Market Value Share, By Type, 2022 (E)
Figure 132: South Africa Coagulation Factor Concentrates Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the coagulation factor concentrates market enjoy?
The global coagulation factor concentrates market is valued at US$ 7.8 billion.
What value will the coagulation factor concentrates market reach by 2027?
The market for coagulation factor concentrates is projected to reach US$ 11.4 billion by 2027.
At what pace is the market expected to expand through 2027?
Global sales of coagulation factor concentrates are anticipated to evolve at 7.8% CAGR over the next five years.
What is the expected market valuation for China by the end of the forecast period?
The China coagulation factor concentrates market is set to be valued at US$ 2.5 billion by 2027.
At what CAGR will the market expand in Canada?
From 2022 to 2027, the Canada coagulation factor concentrates market is projected to expand at 6.4% CAGR.
Which key coagulation factor concentrate companies are profiled in this Fact.MR research?
Leading market players are CSL Behring, Shire, Kedrion S.P.A., Grifols, Baxter International Inc., Octapharma, LFB, Novo Nordisk A/S, Biotest, and Green Cross Corporation.
Coagulation Factor Concentrates Market